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Abstract
Background: We have previously shown that toll-like receptor 3 (TLR3)-mediated signaling plays an important role
in the induction of innate cytokine responses to Theiler’s murine encephalomyelitis virus (TMEV) infection. In
addition, cytokine levels produced after TMEV infection are significantly higher in the glial cells of susceptible SJL
mice compared to those of resistant C57BL/6 mice. However, it is not known whether TLR3-mediated signaling
plays a protective or pathogenic role in the development of demyelinating disease.
Methods: SJL/J and B6;129S-Tlr3tm1Flv/J (TLR3KO-B6) mice, and TLR3KO-SJL mice that TLR3KO-B6 mice were
backcrossed to SJL/J mice for 6 generations were infected with Theiler’s murine encephalomyelitis virus (2 × 105
PFU) with or without treatment with 50 μg of poly IC. Cytokine production and immune responses in the CNS and
periphery of infected mice were analyzed.
Results: We investigated the role of TLR3-mediated signaling in the protection and pathogenesis of TMEV-induced
demyelinating disease. TLR3KO-B6 mice did not develop demyelinating disease although they displayed elevated
viral loads in the CNS. However, TLR3KO-SJL mice displayed increased viral loads and cellular infiltration in the CNS,
accompanied by exacerbated development of demyelinating disease, compared to the normal littermate mice.
Late, but not early, anti-viral CD4+ and CD8+ T cell responses in the CNS were compromised in TLR3KO-SJL mice.
However, activation of TLR3 with poly IC prior to viral infection also exacerbated disease development, whereas
such activation after viral infection restrained disease development. Activation of TLR3 signaling prior to viral
infection hindered the induction of protective IFN-g-producing CD4+ and CD8+ T cell populations. In contrast,
activation of these signals after viral infection improved the induction of IFN-g-producing CD4+ and CD8+ T cells. In
addition, poly IC-pretreated mice displayed elevated PDL-1 and regulatory FoxP3+ CD4+ T cells in the CNS, while
poly IC-post-treated mice expressed reduced levels of PDL-1 and FoxP3+ CD4+ T cells.
Conclusions: These results suggest that TLR3-mediated signaling during viral infection protects against
demyelinating disease by reducing the viral load and modulating immune responses. In contrast, premature
activation of TLR3 signal transduction prior to viral infection leads to pathogenesis via over-activation of the
pathogenic immune response.
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Background
Toll-like receptor 3 (TLR3) recognizes double stranded
RNA (dsRNA), including poly IC and viral dsRNAs.
TLR3 activation induces the production of a variety of
cytokines, such as IL-1b, IL-6 and type I interferon
(IFN) [1-4]. However, the role that TLR3 activation
plays in the protection from or pathogenesis of virus-
induced chronic disease is still unclear. It has been
reported that a dominant-negative TLR3 allele is asso-
ciated with the development of herpes simplex encepha-
litis, suggesting that TLR3 plays a protective role in
herpes simplex virus infection [5]. In addition, TLR3
appears to play a protective role against infections with
West Nile virus (WNV) [6], Coxsackievirus B4 [7], and
mouse cytomegalovirus [8]. However, a detrimental role
of TLR3 in the induction of acute pneumonia following
influenza A virus infection has also been reported [9]. In
addition, several studies have indicated that TLR3-
mediated signals play either no role or a pathogenic role
in viral diseases. For example, a recent study demon-
strated that the absence of TLR3 did not alter viral
pathogenesis after infection with single-stranded or dou-
ble-stranded RNA viruses, such as lymphocytic chorio-
meningitis virus, vesicular stomatitis virus, and reovirus
[10]. Furthermore, TLR3-deficient mice were more resis-
tant to lethal WNV infection, although a TLR3-
mediated signal was critical for the virus to penetrate
into the brain where it caused neuropathogenesis [11].
Theiler’s murine encephalomyelitis virus (TMEV) is a
positive sense single-stranded RNA (ssRNA) virus of the
Picornaviridae family [12]. TMEV establishes a persis-
tent CNS infection in susceptible mouse strains that
results in the development of demyelinating disease,
which is considered a relevant viral model for human
multiple sclerosis [13-15]. It has previously been shown
that TLR3 recognizes the dsRNAs generated as TMEV
replication intermediates, and TLR3 is essential for the
production of TMEV-induced inflammatory cytokines,
such as type I IFNs [16,17]. TLR3 is constitutively
expressed in a variety of cells, including antigen present-
ing cells (dendritic cells and macrophages) as well as
glial cells, including microglia and astrocytes [18]. In
addition, the expression level of TLR3 is upregulated
following TMEV infection and its expression levels are
particularly high in cells from susceptible mice [19,20].
Furthermore, antigen presenting cells in the periphery
and glial cells in the CNS are much more permissive to
TMEV infection and support viral replication better
than cells from resistant mice [21,22]. The differences
appear to be, in part, due to the high intrinsic activation
state of NF-B in cells from susceptible mice [23].
TLR3-mediated signals activate multiple NF-B path-
ways and upregulate the expression of other TLRs, such
as TLR2, and following TMEV infection, these second-
ary TLRs contribute to the production of additional
proinflammatory cytokines [17,24]. However, dsRNAs,
including synthetic dsRNA poly IC, are recognized not
only by TLR3 but also by MDA5 and PKR [16,24].
Therefore, the relative role of TLR3-mediated signaling
in the development of TMEV-induced demyelinating
disease remains to be determined.
In particular, the induction of strong type I IFN pro-
duction, following infection with TMEV, is mediated by
TLR3 and MDA5-mediated signals [16,17,24,25]. Our
previous results showed that type I IFN was critical for
the prevention of rapid fatal encephalitis, by controlling
the viral load and the infiltration of inflammatory cells
into the CNS [26]. However, type I IFN levels were sig-
nificantly higher in susceptible SJL mice compared to
resistant C57BL/6 mice [22]. Interestingly, type I IFNs
play dichotomous roles in stimulating the immune
responses, i.e., up- or down-regulating T cell responses,
apparently depending on IFN concentration [21,27].
Furthermore, the time of type I IFN presence seems to
be an important factor for the function of type I IFNs
against viral infection [21]. Many recent studies utilized
poly IC to activate TLR3 and/or MDA5-mediated sig-
nals in conjunction with viral infections and/or autoim-
munity. For example, poly IC treatment of virus-infected
mice resulted in a type I IFN-dependent reduction in
viral loads and protection from virus-induced disease by
enhancing the function of virus-specific T cells [28,29].
However, treatment with poly IC enhances the develop-
ment of autoimmune diseases [30-32]. Therefore, it
would be important to investigate the effects of different
levels of type I IFNs that are activated via TLR3 in resis-
tant and susceptible mice to determine its impact on the
development of TMEV-induced demyelinating disease,
which bears both viral and autoimmunity components.
To investigate the role of TLR3-mediated innate
immune responses on the pathogenesis of TMEV-
induced demyelinating disease, we utilized TLR3-defi-
cient mice in both the resistant C57BL/6 (B6) and sus-
ceptible SJL/J backgrounds. In addition, we administered
poly IC to activate TLR3-mediated signals prior to or
after TMEV infection. Our results showed that TLR3-
deficient susceptible SJL mice accelerated the develop-
ment of demyelinating disease, whereas TLR3-deficient
resistant B6 mice remained disease free. The virus-
infected TLR3-deficient SJL mice displayed increased
cellular infiltration and an elevated viral load in the
CNS. Therefore, TLR3-mediated signals are important
in protecting susceptible mice from the development of
TMEV-induced demyelinating disease, although TLR3-
mediated signals appear to play a minor role in resistant
mice. However, treatment with poly IC prior to viral
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infection exacerbated disease development in susceptible
mice, while treatment after viral infection somewhat
ameliorated it. This observation suggests that either a
premature activation or an over-activation of TLR3 sig-
naling during early viral infection may lead to pathogen-
esis, perhaps through the development of a pathogenic
immune response. Therefore, our current results
strongly warrant caution on the use of TLR3-mediated
immune interventions against chronic viral diseases and
suggest careful consideration for these treatments in
conjunction with the time of viral infection.
Materials and methods
Mice
SJL/J mice were purchased from the Charles River
Laboratories (Charles River, MA) through the National
Cancer Institute (Frederick, MD). B6; 129S-Tlr3tm1Flv/J
mice (TLR3KO-B6) were purchased from Jackson
Laboratories (Bar Harbor, ME). TLR3KO-B6 mice were
backcrossed to SJL/J mice for 6 generations to obtain
TLR3KO-SJL mice. The absence/presence of TLR3 in
TLR3KO-SJL and the littermate mice (NLM) were typed
based on the electrophoresis patterns of TLR3 and neo-
mycin resistant genes. PCR products from tail genomic
DNA of NLM and TLR3KO-SJL mice were determined
using PCR-based genotyping analysis established by the
Jackson Laboratory (Additional file 1, Figure S1). Experi-
mental procedures that were approved by the Animal
Care and Use Committee of Northwestern University in
accordance with NIH animal care guidelines were used
in this study.
Virus
The BeAn and GDVII strains of TMEV were propagated
in BHK-21 cells grown in DMEM medium supplemen-
ted with 7.5% donor calf serum. Viral titer was deter-
mined by plaque assay on BHK cell monolayers. The
cells were incubated for 4-5 days in infection-medium
(DMEM supplemented with 0.1% bovine serum albu-
min) with TMEV at 10 MOIs and the cell lysates were
cleared by centrifugation. The cleared lysates yield 3-5 ×
108 PFU and a pooled batch was used as a viral stock. If
necessary the viral stock was diluted in DMEM before
inoculation.
Assessment of clinical signs
Approximately 30 μl of TMEV was injected into the
right hemisphere of 5- to 7-week-old mice anesthetized
with isofluorane. Resistant B6 and TLR3KO-B6 mice
were infected with 1 × 106 PFU and susceptible SJL and
TLR3KO-SJL mice were infected with 2 × 105 PFU
TMEV. Clinical symptoms of disease were assessed
weekly on the following grading scale: grade 0 = no clin-
ical signs; grade 1 = mild waddling gait; grade 2 =
moderate waddling gait and hindlimb paresis; grade 3 =
severe hind limb paralysis; grade 4 = severe hind limb
paralysis and loss of righting reflex; and grade 5 = death.
Plaque assay
After cardiac perfusion with cold Hank’s balanced salt
solution (HBSS) (Mediatech), brain and spinal cords
were removed. The tissues were homogenized in HBSS
using a tissue homogenizer. A standard plaque assay
was performed on BHK-21 cell monolayers [33]. Plaques
in the BHK monolayer were visualized by staining with
0.1% crystal violet solution after fixing with methanol.
Isolation of CNS-infiltrating lymphocytes
Mice were perfused through the left ventricle with 30
ml of sterile HBSS. Excised brains and spinal cords were
forced through wire mesh and incubated at 37°C for 45
min in 250 μg/ml of collagenase type 4 (Worthington).
CNS-infiltrating lymphocytes were then enriched at the
bottom 1/3 of a continuous 100% Percoll (GE) gradient
after centrifugation for 30 min at 27,000 × g.
Flow cytometry
CNS-infiltrating lymphocytes were isolated and Fc
receptors were blocked using 100 μl of 2.4G2 hybridoma
(ATCC) supernatant by incubating at 4°C for 30 min-
utes. The indicated antibodies were subsequently used
to stain various cell types. VP3159-166-loaded H-2K
s tet-
ramer labeled with PE was used to assess levels of virus-
specific CD8+ T cells in the CNS of TMEV-infected
mice. Cells were analyzed using a Becton Dickinson
LSRII flow cytometer.
Intracellular cytokine staining
Freshly isolated CNS-infiltrating mononuclear cells were
cultured in 96-well round bottom plates in the presence
of viral or control peptides and Golgi-Plug™ (BD) for 6
h at 37°C. Cells were then incubated in 100 μl of 2.4G2
hybridoma (ATCC) supernatant for 30 minutes at 4°C
to block Fc receptors. Anti-CD8 (clone 53-6.7) antibody
or anti-CD4 (clone L3T4) antibody was added, and cells
were incubated for an additional 30 minutes at 4°C.
After two washes, intracellular IFN-g staining was per-
formed according to the manufacturer’s instructions
(BD) using PE-labeled rat monoclonal anti-IFN-g
(XMG1.2) antibody. Cells were analyzed by flow
cytometry.
RT-PCR and real-time PCR
Total RNA was isolated by TRIzol reagent (Invitrogen)
and reverse transcribed to cDNA using Moloney murine
leukemia virus reverse transcriptase (Invitrogen). The
cDNAs were amplified with specific primer sets using
the SYBR Green Supermix (Bio-Rad) on an iCycler (Bio-
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Rad). The sense and antisense primer sequences used





CAGGAAG -3’ and 5’-GGCTCTCCAGA-CTTC TG
CTC-3’); IFN-b, (5’-CCCTATGGAGATGACGGAGA-3’
and 5’-CTGTCTGCTGG-TGGAGTTGA-3’); IFN-g, (5’-
ACTGGCAAAAGGATGGTGAC-3’ and 5’-TGAGCT-





TGA-3’ and 5’-TCCACGATTTCCCAGAGAAC-3’); IL-
17, (5’-GGGGATCCATGAGTCCAGGGAGAGC-3’ and
5’-CCCTCGAGTTAGGCTGCCTGGCGGA-3’); CX
CL10, (5’-AAGTGCTGCCGTC-ATTTTCT-3’ and 5’-
GTGGCAATGATCTCAACACG-3’) and GAPDH, (5’-
AACTTTGG-CATTGTGGAAGGGCTC-3’ and 5’-TG
CCTGCTTCACCACCTTCTTGAT-3’). GAPDH expres-
sion served as an internal reference for normalization.
Real-time PCR was performed in triplicate.
Statistical analyses
The statistical significance of the differences between
experimental groups (two-tailed p value) was analyzed
with the unpaired Student’s t-test using the InStat Pro-
gram (GraphPAD). Comparisons of the disease courses
between 2 groups were also performed using the paired
t-test. Values of P < 0.05 were considered to be
significant.
Results
TLR3 deficiency in resistant B6 mice does not cause
demyelinating disease by BeAn but results in elevated
encephalitic death by the virulent GDVII strain of TMEV
It has previously been reported that TLR3 plays a criti-
cal role in TMEV-induced inflammatory cytokine and
chemokine responses [16,17]. To examine the role of
TLR3 in the development of TMEV-induced disease, we
compared the development of clinical signs and viral
loads in the CNS of control B6 and TLR3-deficient B6
(TLR3KO-B6) mice following infection with the BeAn
strain of TMEV (1 × 106 PFU). Viral levels in the CNS
of TLR3KO-B6 mice at 7 and 21 days post-infection
(dpi) were significantly higher in the brain and spinal
cord than the viral levels of the B6 control mice (Figure
1A). However, neither the B6 nor the TLR3KO-B6 mice
developed detectable clinical signs of disease (data not
shown). These results indicate that TLR3 signals are
important in controlling TMEV loads in the CNS,
although the increased viral levels did not lead to the
development of demyelinating disease. Flow cytometric
analysis of the CNS cells indicated that the level of
mononuclear cells, including T cells and macrophages,
that infiltrated the CNS of the TLR3KO-B6 mice were
similar to those of the B6 mice at 7 dpi (Figure 1B).
However, the levels of these cells in the CNS of
TLR3KO-B6 mice were significantly higher than those
of control B6 mice at 21 dpi. The elevated viral load in
the TLR3KO mice may have caused a higher cellular
infiltration into the CNS by activating higher levels of
inflammatory cytokines and chemokines. To further
determine the levels of virus-specific CD4+ and CD8+ T
cells that infiltrated into the CNS, mononuclear cells
were isolated from the CNS of TMEV-infected mice at
7 and 21 dpi, and these cells were stimulated with
TMEV-specific viral epitope peptides. Subsequently, the
ability of these T cells to produce IFN-g was assessed by
flow cytometry after intracellular cytokine staining (Fig-
ure 1C). The proportions of IFN-g-producing, TMEV-
specific CD4+ T cells and CD8+ T cells in the CNS were
similar between TLR3KO-B6 and B6 mice.
As there were no differences in the development of
TMEV BeAn-induced demyelinating disease between
TLR3KO-B6 and B6 control mice, we further explored
the potential differences in the susceptibility of these
mice to a highly virulent GDVII strain of TMEV [34]
that was administered via intraperitoneal injection (Fig-
ure 1D). After a low dose of viral infection (100 PFU),
fewer than 26% of the control B6 mice developed fatal
encephalitis, whereas greater than 50% of TLR3KO-B6
mice developed disease. In addition, virus-infected
TLR3KO mice showed significantly higher levels of viral
load in the CNS at 7 dpi compared to the infected B6
mice (Figure 1E), consistent with the differences noted
in disease severity. These results indicate that TLR3-
mediated signaling in resistant B6 mice plays an impor-
tant role in controlling viral infection, particularly for
highly virulent, encephalitic strains of TMEV.
TLR3-deficient SJL (TLR3KO-SJL) mice are more
susceptible to BeAn-induced demyelinating disease than
SJL mice
To examine whether TLR3 plays a more prominent
role in TMEV-susceptible SJL mice, we infected
TLR3KO-SJL mice and normal littermates (NLM) at
the 6th generation of backcrossing to SJL/J mice with a
low dose (2 × 105 PFU) of TMEV BeAn. These virus-
infected mice were then assessed for the progression of
demyelinating disease for 80 dpi (Figure 2A). We chose
the low dose of the virus to maximize the differences
in disease development. Interestingly, TLR3KO-SJL
mice showed exacerbated development of TMEV-
induced demyelinating disease compared to the NLM.
We further examined the viral loads in the CNS
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(brains and spinal cords) of both mouse groups at 7,
21 and 50 dpi using plaque assays (Figure 2B). The
levels of infectious virus in the CNS of TLR3KO-SJL
mice were significantly higher both in the brain and
spinal cord compared to those for the control NLM
mice. These results indicate that TLR3 signaling plays
an important role in controlling viral load in the CNS
and in preventing the development of TMEV-induced
demyelinating disease following infection with a less
virulent BeAn strain in mice of the susceptible SJL
background, unlike mice of the resistant B6
background.
Figure 1 Decreased TMEV clearance in the CNS of TLR3 KO mice. (A) The level of infectious TMEV in the whole brain (BR) and spinal cord
(SC) from wild type and TLR3 KO mice at 7 and 21 days postinfection (1 × 106 PFU) was determined by plaque assays in BHK cells. (P < 0.05 at
all time points based on the paired Student’s t test). Data represent values from a representative experiment from three independent
experiments conducted with CNS pools of three mice per group. The values given are means ± standard deviations of triplicates. Statistically
significant differences were indicated with asterisks (*, P < 0.05; ***, P < 0.001). (B) CNS-infiltrating mononuclear cells from TMEV-infected wild
type and TLR3 KO mice at 7 and 21 dpi. Numbers in FACS plots represent percentages in the CNS. Data are representative of three experiments
using three mice per group. (C) Levels of IFN-g producing CD4+ and CD8+ cells in the CNS were determined by intracellular staining after
stimulation for 6 hr with 2 μM CD4 or CD8 viral epitope peptides. Numbers in the FACS plots represent % of IFN-g producing CD4+ or CD8+
cells from total infiltrating CD4+ or CD8+ cells. The data represent three separate experiments using three mice per group. (D) Survival rate of
wild type and TLR3KO mice after intraperitoneal infection with GDVII was monitored for 20 days. (E) Viral persistence levels in the brain (BR) and
spinal cord (SC) of infected mice at 7 dpi (DPI) were determined by quantitative PCR. Data are expressed by fold induction after normalization to
GAPDH mRNA levels. The values given are means ± standard deviations of triplicates. Statistically significant differences were indicated with
asterisks (***, P < 0.001)
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TLR3KO-SJL mice display severe demyelination and
inflammation in the CNS
To compare levels of demyelination in the CNS of
TMEV BeAn-infected TLR3KO-SJL and NLM SJL mice,
histopathologic examinations were performed (Figure 3).
First, Hematoxylin-eosin (HE) staining (Figure 3Aa and
3Ad), Kluver-Barrera’s (KB) staining (Figure 3Ab and
3Ae) and immunohistochemical staining for GFAP (Fig-
ure 3Ac and 3Af) were conducted. In each experiment,
mice from the NLM or TLR3KO groups were blindly
selected, beforehand, for histological examination, and
these mice were sacrificed at 27 dpi. The HE staining
results showed that slight mononuclear cell infiltration
(arrow) and mild demyelination were observed in the
white matter of the spinal cord from NLM mice (Figure
3Aa and 3Ab). GFAP staining showed a lack of astro-
cytes in the demyelinated lesion (arrow) (Figure 3Ac). In
contrast, markedly increased mononuclear cell infiltra-
tion (arrow) and extended demyelination (arrow) were
observed in the white matter of the spinal cord from
TLR3KO mice (Figure 3Ad and 3Ae). GFAP staining
showed markedly increased number of activated astro-
cytes in the white matter of the spinal cords of these
mice (Figure 3Af).
Next, we examined the spinal cords of TMEV-infected
NLM and TLR3KO-SJL mice at days 10 and 27 post
infection using immunohistochemical staining for CD3,
a marker of T cells (Figure 3Ba, 3Bd, 3Bg, and 3Bj);
CD45R, a marker of B cell (Figure 3Bb, 3Be, 3Bh, and
3Bk); and F4/80, a marker of macrophages (Figure 3Bc,
3Bf, 3Bi, and 3Bl). Increased T cell infiltration was
observed in the white matter of the spinal cord from
TLR3KO mice (Figure 3Bd and 3Bj) compared to NLM
mice (Figure 3Ba and 3Bg), based on immunohisto-
chemical staining for CD3. Few B cells were observed in
the NLM (Figure 3Bb) and the TLR3KO mice at day 10
post-infection (Figure 3Be). On day 27 post-infection, B
cell infiltration was increased in the white matter of the
spinal cord from TLR3KO mice (Figure 3Bk) compared
to NLM mice (Figure 3Bh). Similarly, macrophage infil-
tration was determined by staining for the F4/80 mar-
ker, and higher levels of macrophages were found in the
white matter of the spinal cord from TLR3KO mice
(Figure 3Bf and 3Bl) compared to NLM mice (Figure
3Bc and 3Bi) at 10 and 27 dpi.
Levels of cellular infiltration, viral load and type I IFN
production are elevated in the CNS of TLR3-deficient
mice
To determine the levels of CNS-infiltrating mononuclear
cells, we compared the mononuclear cells that accumu-
lated in the CNS of NLM and TLR3K-SJL mice. The
numbers of CNS-infiltrating mononuclear cells were ele-
vated throughout the course of viral infection (days 7,
21 and 80) in TLR3KO-SJL mice compared to NLM
(Figure 4A). Flow cytometric analysis of the CNS infil-
trating mononuclear cells indicated that the proportions
of both the CD4+ and CD8+ T cells in TLR3KO-SJL
mice were significantly higher than those of the NLM
group at 7 and 21 dpi (Figure 4B). The proportions of
macrophages (CD11b+CD45high) and neutrophils (Ly6G/
6C+) were also higher in TLR3KO-SJL mice compared
to NLM.
To understand the underlying mechanisms of exacer-
bated susceptibility to TMEV-induced demyelinating
disease in TLR3KO-SJL mice, we compared the expres-
sion levels of TMEV RNA and cytokine genes in the
CNS of virus-infected NLM and TLR3KO-SJL mice at 7
and 21 dpi (Figure 4C). The viral message level was sig-
nificantly elevated at both time points in TLR3KO-SJJL
mice, consistent with the higher replicating virus levels
determined using plaque assays (Figure 2B). The expres-
sion of various inflammatory cytokine genes, such as
type I IFNs, IL-10, TNF-a, IL-6, and IL-1 was similarly
elevated in the CNS of TLR3KO-SJL mice. It was inter-
esting to note that the expression of CXCL-10, asso-
ciated with T cell infiltration to the CNS, was also
highly elevated in TLR3KO-SJL mice. Because TLR3 is
Figure 2 The course of TMEV-induced demyelinating disease
development and viral persistence levels in NLM and TLR3KO-
SJL mice. (A) Frequency and severity of demyelinating disease in
NLM (n = 10) and TLR3KO-SJL (n = 10) were monitored for 80 days
after TMEV infection. (B) Viral persistence levels in the brain (BR) and
spinal cord (SC) of infected mice at 7, 21 and 50 dpi (DPI) were
determined by plaque assay. Data represent values from a
representative experiment from three independent experiments
conducted with CNS pools of three mice per group. Statistically
significant differences were indicated with asterisks (**, P < 0.01; ***,
P < 0.001).
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Figure 3 Histopathology of TMEV-infected NLM and TLR3KO-SJL mice. (A) Hematoxylin-eosin (HE) staining (a, d), Kluver-Barrera (KB) staining
(b, e) and immunohistochemical staining for GFAP, astrocyte marker (c, f) of spinal cord from NLM or TLR3KO-SJL mice were done at 27 dpi
(DPI). Original magnification, 100×. (B) Immunohistochemical staining for CD3 (a, d, g, and j), CD45R, a marker of B cell (b, e, h, and k), and F4/80,
a marker of macrophage (c, f, i, and l) of the spinal cord from NLM or TLR3KO-SJL mice were done at days 10 and 27 post infection. Original
magnification, 400×.
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known to play an important role in activating the
expression of these cytokine genes [16], an increased
viral load in the absence of TLR3 signaling may be suffi-
cient to overcome the TLR3 deficiency via other recep-
tors, such as MDA5, leading to elevated cytokine gene
expression. Consequently, higher viral loads accompa-
nied by more proinflammatory cytokines may result in
elevated cellular infiltration and exacerbated develop-
ment of demyelinating disease in TLR3KO-SJL mice.
Late, but not early, anti-viral T cell responses are
compromised in TLR3KO-SJL mice
To determine the levels of virus-specific T cell responses
in the CNS, mononuclear cells isolated from the CNS of
TMEV-infected NLM and TLR3KO-SJL mice at 7 and
21 dpi were stimulated with viral epitope peptides and
assayed for the production of IFN-g (Figure 5A-D). The
proportion of TMEV-specific IFN-g-producing CD4+ T
cells and CD8+ T cells in the CNS of TLR3KO-SJL mice
Figure 4 CNS-infiltrating mononuclear cells from TMEV-infected NLM and TLR3KO-SJL mice. (A) Overall numbers of CNS-infiltrating
mononuclear cells in the CNS of TMEV-infected NLM and TLR3KO-SJL at 7, 21, and 80 DPI were shown. The values given are means ± standard
deviations of 2-3 independent experiments derived from pooled cells of 3-4 mice per group. (B) Levels of T cells (CD4+ and CD8+), macrophages
(CD11b+ CD45high) and granulocytes (Ly6G/6C+ and CD45+) were assessed using flow cytometry. Numbers in the FACS plots represent
percentages in the CNS of TMEV-infected NLM and TLR3KO-SJL at 7 and 21 dpi. (C) Cytokine mRNA expression levels in the CNS of NLM and
TLR3KO-SJL at 7 and 21 dpi were analyzed by quantitative PCR. Data are expressed by fold induction after normalization to the GAPDH mRNA
levels. The values given are means ± standard deviations of triplicates. Statistically significant differences were indicated with asterisks (*, P < 0.05;
**, P < 0.01; ***, P < 0.001). A representative result of three separate experiments using three mice per group was shown here.
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Figure 5 CD4+ and CD8+ T cell responses to viral epitopes in TMEV-infected NLM and TLR3KO-SJL mice. (A) Proportions of IFN-g-
producing CD4+ cells in the CNS were determined by intracellular staining after stimulation with 2 μM of SJL CD4 capsid (SJL SP) or SJL CD4
noncapsid (SJL NSP) epitope mixtures. Numbers in the FACS plots represent % of IFN-g producing CD4+ cells from total infiltrating CD4+ cells. (C)
IFN-g-producing CD4+ cell numbers in the CNS at 7 and 21 dpi were shown after stimulation with SJL CD4 capsid (SJL SP) (left panel) or SJL
CD4 noncapsid (SJL NSP) (right panel) epitope mixtures. (B) Proportions of IFN-g-producing CD8+ cells in the CNS were determined by
intracellular staining after stimulation with 2 μM of SJL CD8 epitope mixture. Numbers in the FACS plots represent % of IFN-g producing CD8+
cells from total infiltrating CD8+ cells. Numbers in the bottom panel represent % of H-2Ks-VP3159-166 tetramer-positive CD8
+ cells from total
infiltrating CD8+ cells without further stimulation. (D) IFN-g-producing CD8+ cell numbers after stimulation with SJL CD8 epitopes (left panel) and
total numbers of H-2Ks-VP3159-166 tetramer-reactive CD8
+ cells in the CNS at 7 and 21 dpi were shown (right panel). (E) The relative expression
levels of IFN-g vs. IL-17 mRNAs in the CNS of virus-infected TLR3KO-SJL and NLM were assessed by real-time PCR. Data are expressed by fold
induction after normalization to the GAPDH mRNA levels. The values given are means ± standard deviations of triplicates. Statistically significant
differences were indicated with asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.001). (F) Expression of CD69, activation marker of CD4 and CD8 from
TMEV-infected NLM and TLR3KO-SJL mice at 7 DPI was analyzed by FACS. Numbers in cytometric plots represent % of positive CD4+ or CD8+ T
cells out of the total CD4+ or CD8+ T cells, respectively. (G) Expression levels of MHC class I (H-2Ks) and II (I-As) molecules on microglia (MG) and
macrophages (MP) of TMEV-infected NLM and TLR3KO-SJL mice were analyzed at 7 dpi by flow cytometry. Numbers in cytometric plots
represent % of positive MG or MP out of the total MG or MP, respectively.
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were consistently similar or higher than those of the
NLM mice at 7 dpi. The proportion of H-2Ks-VP3159-
166-tetramer reactive CD8
+ T cells in the CNS of
TLR3KO mice was also similar to that of the NLM mice
at the early stage (7 dpi) of infection, indicating the
similarities in the function of virus-specific CD8+ T cells
in both mouse groups. However, the overall numbers of
virus-specific CD4+ and CD8+ T cells in the CNS were
higher due to the increased cellular infiltration to the
CNS in TLR3KO-SJL mice. The proportion and number
of anti-viral CD4+ T cells became similar or lower in
the mice at 21 dpi. Similarly, VP3159-166-tetramer reac-
tive CD8+ T cells were lower at 21 dpi in the TLR3KO-
SJL mice, although IFN-g-producing CD8+ T cells
remained similar. It has previously been shown that
Th17 cells are preferentially developed following TMEV
infection and IL-17 promotes the pathogenesis of
chronic demyelinating disease [35]. To further deter-
mine the levels of IL-17-producing T cells relative to
IFN-g-producing cells in the virus-infected mice, the
overall levels of IFN-g and IL-17 messages expressed in
the CNS were assessed using real-time PCR (Figure 5E).
The results confirmed the higher level of IFN-g-produ-
cing cells observed by flow cytometry in virus-infected
TLR3KO-SJL mice. In addition, the level of IL-17-pro-
ducing T cells was similarly higher in TLR3KO mice
compared to the control littermates. These results sug-
gest that antiviral T cell responses are not drastically
altered but rather, are elevated in TMEV-infected SJL
mice in the absence of TLR3 signals.
To further examine the status of T cell activation in
TLR3KO-SJL mice during early viral infection, the
expression of the CD69 activation marker on T cells
and MHC molecules on microglia and macrophages in
the CNS of virus-infected mice were analyzed at 7 dpi
by flow cytometry (Figure 5F and 5G). Levels of CD69
expression on CD4+ and CD8+ T cells were higher in
the TLR3KO-SJL mice compared to NLM mice, consis-
tent with the higher proportions of virus-specific T cells
(Figure 5A and 5B). The expression levels of both MHC
class I (H-2Ks) and II (I-As) molecules were also higher
on microglia (MG) and macrophages (MP) from
TMEV-infected TLR3KO mice (Figure 5G). These
results suggest that early efficient T cell activation, in
the absence of TLR3 signaling, may be due to the ele-
vated expression of MHC molecules on antigen present-
ing cells.
Treatment of SJL mice with poly IC prior to viral
infection, not after infection, exacerbates disease
development, accompanied with elevated cellular
infiltration to the CNS
To activate TLR3 signaling, susceptible SJL mice were
intraperitoneally treated with poly IC, the representative
TLR3 ligand, at 1 day prior to or 8 days post TMEV-
infection. The progression of TMEV-induced demyeli-
nating disease was assessed over 63 dpi. Mice treated
with poly IC at 1 day prior to viral infection displayed
an exacerbated development of disease, whereas mice
treated with poly IC at 8 dpi resulted in a slower onset
of the disease compared to virus-infected SJL mice with-
out poly IC administration (Figure 6A). Viral message
levels in the brain and spinal cord of mice pretreated
with poly IC were significantly higher than those of the
mice that were either untreated or treated with poly IC
at 8 dpi (Figure 6B). These results indicate that the acti-
vation of TLR3 prior to viral infection leads to an
increased viral load in the CNS and accelerated patho-
genesis of demyelinating disease; however, such activa-
tion after viral infection does not alter the development
of disease.
To further understand the immunological mechanisms
of the acceleration of TMEV-induced demyelinating dis-
ease in poly IC-pretreated SJL mice, we first compared
the levels of mononuclear cells accumulated in the CNS
of mice at 14 and 28 dpi (Figure 6C and 6D). Flow cyto-
metric analysis showed that the proportion of macro-
phages (CD11b+CD45high) in the CNS of poly IC
pretreatment mice was elevated, whereas the proportion
in the CNS of poly IC post-treated mice remained the
same as that of virus-infected mice without poly IC
treatment (Figure 6C). It is interesting to note that poly
IC-pretreated mice maintained the elevated macrophage
level at 28 dpi, while in poly IC-post-treated mice the
level decreased. Similarly, the proportion of CD4+ and
CD8+ cells was higher in the CNS of the poly IC pre-
treatment mice and remained higher at 28 dpi compared
to the untreated virus-infected mice. However, the pro-
portion of these T cells in the CNS of poly IC-post-trea-
ted mice was lower (Figure 6D), and these decreases
appear to reflect decreased levels of viral message in the
CNS (Figure 6B).
To further assess the relative levels of virus-specific T
cell responses in the CNS of these poly IC treated mice,
mononuclear cells isolated from the CNS of infected
mice at 14 and 28 dpi were stimulated with viral epitope
peptides to determine the ability of these cells to pro-
duce IFN-g. The flow cytometry profiles of the mono-
nuclear cells at day 28 post-infection are shown in
Figure 6 (panels E and F). The proportions of both IFN-
g-producing virus-specific CD4+ and CD8+ T cells in the
CNS of poly IC pre-treated mice were markedly
decreased at both time points (results at day 14 post-
infection not shown) compared to those of the control
mice without poly IC-treatment. In contrast, the propor-
tion of CD4+ and CD8+ T cells in the poly IC-post-trea-
ted mice were increased particularly around the onset of
disease development (28 dpi). These results strongly
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Figure 6 Administration of poly IC at 1 day prior to or 8 days post TMEV infection into SJL mice. Mice were intraperitoneally injected
with either PBS or 50 μg of poly IC (Sigma) in 100 μl at day -1 or +8 relative to viral infection. (A) Frequency and severity of demyelinating
disease in SJL mice after ip injection with poly IC at 1 day prior to (n = 10) or 8 days post (n = 10) TMEV infection were monitored for 63 days
after TMEV infection. Statistically significant differences in Student’s t-test were indicated with asterisks (*, P < 0.05). Paired t-tests (two-tailed)
between 20-63 dpi indicated that the difference between untreated and pretreated groups was very significant (P < 0.0026) and the difference
between untreated and post-treated groups was significant (P < 0.0189). (B) Viral persistence levels in the brain (BR) and spinal cord (SC) of
infected mice at 14 dpi were determined using quantitative PCR. Data are expressed by fold induction after normalization to the GAPDH mRNA
levels. The values given are means ± standard deviations of triplicates. Statistically significant differences were indicated with asterisks (*, P < 0.05;
**, P < 0.01; ***, P < 0.001). (C and D) CNS-infiltrating mononuclear cells from SJL mice with treatment of poly IC at -1 day or +8 days post TMEV
infection were shown. Numbers in FACS plots represent percentages in the total CNS-infiltrating cells. Data are representative of three
experiments using three mice per group. (E) Levels of IFN-g producing CD4+ cells in the CNS were determined by intracellular staining after
stimulation for 6 hours with 2 μM CD4 epitope peptides at 28 dpi. (F) Levels of IFN-g producing CD8+ cells in the CNS were determined by
intracellular staining after stimulation for 6 hours with 2 μM CD8 viral epitope peptides at 28 dpi. Numbers in the FACS plots represent
percentages in total CD4 or CD8 cells. Data are representative of three experiments using three mice per group.
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suggest that activation of TLR3 signaling prior to viral
infection hinders the induction of protective IFN-g-pro-
ducing CD4+ as well as CD8+ T cell populations. In
contrast, activation of these signals after viral infection
appears to improve the induction of IFN-g-producing
CD4+ as well as CD8+ T cells.
Expression of antigen presentation-associated molecules
is elevated in CNS CD11b+ cells in poly IC-pretreated
mice but reduced in post-treated mice
To further determine whether the decrease of IFN-g-
producing T cells in poly IC-pretreated mice (Figure 6E
and 6F) reflects the inability of antigen presenting cells
to stimulate T cell responses in the CNS of poly IC pre-
or post-treated SJL mice, expression levels of CD69, an
activation marker of CD4+ and CD8+ cells, were com-
pared at 14 and 28 dpi (Figure 7A). Overall, the expres-
sion levels of CD69 on CD4+ and CD8+ cells were
similar among the untreated control and the poly IC
pre- and post-treated mice at both 14 and 28 dpi,
although the expression of CD69 on CD8+ T cells of
poly IC-post-treated mice was somewhat lower. These
data suggest that the decrease in IFN-g-producing T cell
responses in poly IC-pretreated mice does not reflect
the status of T cell activation in the CNS.
To verify the status of antigen presenting cells in the
CNS, we examined the expression levels of MHC classes
I and II, and CD40 molecules, which are associated with
T cell activation, on the major antigen-presenting
CD11b+ cells, including microglia and macrophages
(Figure 7B and 7C). The expression levels of MHC class
I (H-2Ks) and II (I-As) molecules on CD11b+ cells in the
poly IC pretreated mice were markedly increased,
whereas the levels in the poly IC post-treated mice were
decreased compared to those in the untreated control
virus-infected mice. These data suggested that the poor
IFN-g-producing T cell responses were not due to a
deficiency in the expression of molecules associated
with antigen presentation. It was also interesting to note
that the levels of both T cell activation and expression
of MHC and CD40 molecules appeared to correlate
with viral load in the CNS.
To further explore possible mechanisms underlying
the poor IFN-g-producing T cell responses in poly IC-
pretreated mice, we assessed the expression levels of
PDL-1, an inhibitory molecule for both CD4+ and CD8+
T cell responses [36], on CD11b+ cells in the CNS (Fig-
ure 7D). We chose PDL-1 as a candidate inhibitory
molecule because this molecule is known to play a criti-
cal role in anti-viral T cell functions in virus-infected
hosts, and the expression of PDL-1 is inducible by acti-
vation of TLR3 with poly IC treatment [36,37]. The
expression levels of PDL-1 on CD11b+ cells were drasti-
cally increased in the poly IC pretreated mice at both 14
and 28 dpi, whereas the expression was markedly
decreased in post-treated mice compared to those of
TMEV-infected control mice without poly IC treatment.
These results strongly suggest that the compromise in
the immune response of mice treated with poly IC prior
to virus infection was due in part to the over-expression
of the inhibitory PDL-1 molecule on antigen presenting
cells rather than deficiencies in the activation of T cells.
It is possible that the poor immune responses in the
poly IC-pretreated mice may also have been associated
with the induction of a higher level of regulatory FoxP3
+ CD4+ T cells (Treg), which are known to inhibit the
function of anti-viral T cell responses [38-42]. To exam-
ine this possibility, levels of Foxp3 expressing CD4+ T
cells in the CNS of control mice and mice treated with
poly IC were assessed at 14 and 28 dpi (Figure 7E). The
level of Treg cells in the CNS of poly IC-pretreatment
mice was significantly higher, particularly at the preclini-
cal stage (14 dpi) compared to that of untreated control
mice. In contrast, the Treg levels in mice treated with
poly IC following viral infection were similar to the
untreated control mice. These results suggest that an
elevated induction of FoxP3+ Treg cells may also par-
tially contribute to the low T cell response in poly IC-
pretreated mice.
Discussion
We have previously demonstrated that cells infected
with TMEV stimulate the innate inflammatory response
mainly via TLR3-mediated signaling [16,17]. However,
the role of TMEV-induced TLR3 signaling in protection
from and/or pathogenesis of demyelinating disease
remains unknown. In this study, we examined the
potential role of TLR3 in the progression of TMEV-
induced demyelinating disease by utilizing TLR3 KO
mice and administering TLR3 ligand. Our results
demonstrate that TLR3-mediated signals do not play a
major role in the protection of mice in the resistant
C57BL/6 background against BeAn, a less virulent strain
of TMEV. However, TLR3 stimulation plays a protective
role in infection with GDVII, a neurovirulent TMEV
strain (Figure 1). These results are consistent with pre-
vious studies demonstrating that the absence of TLR3 in
B6 mice does not alter the adaptive immune response
or viral pathogenesis of chronic viral infections [10]. In
contrast, it has also been reported that the presence of
TLR3 provides protection from acute viral infections
with West Nile virus [6] and Coxsackievirus B4 [7].
Therefore, it appears that TLR3 may provide some pro-
tection against acute or virulent viral infections but not
against non-virulent viral infections.
In contrast to resistant C57BL/6 mice, SJL mice are
susceptible to persistent chronic infection in the CNS
with the less virulent BeAn strain of TMEV, and the
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Figure 7 Expressions of CD69, MHC molecules, CD40, PDL-1, and Foxp3 on CNS cells. Expressions of CD69 and FoxP3 molecules on T
cells, and MHC, CD40 and PDL-1 molecules on CD11b+ cells in the CNS of mice were determined at 14 and 28 dpi by flow cytometry. (A)
Expression of the CD69 activation marker on CD4+ and CD8+ T cells. (B) Expression of MHC class I (H-2Ks) and II (I-As) on CD11b+ cells (microglia
and macrophages). Numbers in the FACS plots represent Mean Fluorescence Intensity. Expressions of CD40 (C) and PDL-1 (D) on CNS CD11b+
cells are shown. Numbers in the FACS plots represent percentages in total CD11b+ cells. (E) Expression of Foxp3 on CD4+ cells. Numbers in FACS
plots represent percentages of total CD4+ cells. Data are representative of three experiments using three mice per group.
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majority of infected mice develop demyelinating disease
starting from 20-35 dpi [15]. Our current results indi-
cate that the presence of TLR3-mediated signals pro-
vides protection from the development of TMEV-
induced demyelinating disease in susceptible SJL mice,
as TLR3-deficient mice with the SJL background genes
showed elevated viral loads in the CNS and exacerbated
disease development (Figures 2 and 3). Therefore,
TLR3-mediated protection may play an important role
in the susceptible host that only mounts a marginal pro-
tective response against chronic viral infections. While
the early adaptive immune response to viral infections
was not altered in the absence of TLR3-mediated signals
(Figure 5), consistent with a previous report [10], cellu-
lar infiltration into the CNS was markedly elevated (Fig-
ure 4A and 4B), resulting in exacerbation of TMEV-
induced immune-mediated demyelinating disease (Fig-
ure 2A). The increased cellular infiltration may be due
to high viral loads in the absence of TLR3 signals (Fig-
ure 2B), which leads to high levels of proinflammatory
cytokine production in the CNS, thus facilitating cellular
infiltration (Figure 4C). However, the elevated cytokine
production in the CNS of virus-infected TLR3KO mice
was unexpected, as TLR3 is essential for the production
of cytokines, such as type I IFNs and IL-6, in TMEV
infected glial cells [16,17]. Therefore, these results
strongly suggest that high viral loads in the CNS led to
the utilization of an alternative innate immunity path-
way, such as MDA5 and/or PKR, which stimulate proin-
flammatory cytokine production, as previously described
[4,24,43,44]. Since cells from TLR3KO mice can also
produce cytokines upon stimulation with poly IC, these
alternative signal-triggering molecules appear to be
operational in these mice (not shown). Nevertheless,
TLR3-mediated signals appear to provide a protective
function, particularly in hosts susceptible to virus-
induced disease.
It is interesting to note that there is a disconnect
between the levels of type I IFNs and control of TMEV
infection, hence TRLR3KO mice display higher levels of
type I IFNs yet more susceptible to TMEV infection
(Figures 2 and 4). These results are inconsistent with
the previous studies with IFNIR-KO mice, which dis-
played fatal encephalitis upon TMEV infection [26,45].
Therefore, the presence of a certain level of type I IFN
signaling during early TMEV infection appears to be
necessary for survival of the animals. The high level of
type I IFN production in TLR3KO mice is likely acti-
vated via primarily MDA5 signaling by a high viral load,
because an MDA5-mediated signal is the major activator
for type I IFN production in mice following infection
with TMEV [24,46]. However, high levels of type I IFNs
may not be necessarily helpful in controlling viral infec-
tion. In fact, both IFN-a and IFN-b levels were
significantly higher in mice pretreated with poly IC
compared to either untreated or treated at 8 dpi (Addi-
tional file 2, Figure S2). Furthermore, our previous
results indicated that susceptible SJL mice produce
higher levels of type I IFNs compared to resistant B6
mice and a high level of IFNs exacerbates viral infection
by inhibiting induction of protective immune responses
[21]. Therefore, the exceeding levels of type I IFNs
appear to play a detrimental role in the protection from
virus-induced chronic demyelinating disease.
Interestingly, premature activation of TLR3 via admin-
istration of poly IC prior to viral infection promoted dis-
ease progression. In contrast, additional TLR3 signals by
poly IC after viral infection yielded a clinical improve-
ment and less pathogenic immune responses in the
CNS (Figure 6). These results suggest that TLR3 signal-
ing provides differential protection against viral infec-
tion, depending on the time of the signals with respect
to viral infection. It was previously shown that the pre-
sence of external poly IC mainly stimulates TLR3-
mediated signals for the production of various proin-
flammatory cytokines in many different cell types,
including macrophages, microglia, and astrocytes
[3,16,19]. Poly IC, a TLR3 ligand, has previously been
used to protect the host from acute viral infections.
Administration of poly IC between < 72 hours prior to
infection and < 24 post infection with foot and mouth
disease virus protected mice from death [47]. Similarly,
poly IC treatment at 1 day prior to infection through 4
hours post virus challenge effectively prolonged the sur-
vival of mice from herpes simplex virus 2 challenges
[28]. Therefore, the efficacy of TLR3-mediated protec-
tion from acute viral infection appears to be limited to a
narrow time window. Furthermore, such poly IC treat-
ment prior to viral infection may exacerbate the devel-
opment of chronic virus-infection induced immune-
mediated diseases, such as TMEV-induced demyelinat-
ing disease (Figure 6). Interestingly, it has recently been
shown that poly IC treatment enhances autoimmune
disease in a retinal autoimmunity model [32]. Therefore,
it is conceivable that the exacerbation of virus-induced
disease by pretreatment with poly IC may not be limited
to the development of chronic viral infection-induced
immune mediated disease.
In contrast to the treatment with poly IC prior to viral
infection, poly IC administration at 8 days after TMEV
infection ameliorated disease development (Figure 6A).
Recently, it has been shown that poly IC treatment of
mice at 4 and 8 days after infection with Friend retro-
virus reduces viral loads and promotes protection from
the development of chronic viral infection-induced leu-
kemia over a period of several weeks [29]. Therefore,
TLR3-mediated signaling during chronic viral infection,
particularly infections leading to immune-mediated
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diseases, appears to be protective, whereas premature
activation of the signals prior to and/or at the time of
viral infection may exacerbate the pathogenesis.
Our further analyses of the immune response in poly
IC treated mice showed marked reductions in protec-
tive, virus-specific IFN-g-producing CD4+ and CD8+ T
cell responses in poly IC pretreated mice, in contrast to
increases in poly IC post-treated mice (Figure 6E and
6F). Furthermore, poly IC-pretreated mice displayed ele-
vated expression of a T cell inhibitor, PDL-1, and an
increased generation of regulatory FoxP3+ CD4+ T cells
in the CNS, while poly IC-post-treated mice expressed
reduced levels of PDL-1 and FoxP3+ CD4+ T cells (Fig-
ure 7). The engagement of PD-1/2 or CD80 with PDL-1
exerts a powerful inhibitory function for CD4+ as well
as CD8+ T cells in many virus systems (13). In addition,
poly IC treatment is also known to upregulate PDL-1
expression [36,37]. Furthermore, it is interesting to note
that poly IC-pretreated mice uniquely showed an
increased level of FoxP3+ regulatory CD4+ T cells in the
CNS of virus-infected mice. Although the underlying
mechanisms for the increase are unknown, elevated
levels of cytokines in the CNS of mice with high viral
loads favoring the generation of FoxP3+ CD4+ T cells
may contribute to the increase of the regulatory T cells.
Nevertheless, FoxP3+ CD4+ T cells generated in virus-
infected hosts, including TMEV-infected mice, inhibit
virus-specific CD4+ as well as CD8+ T cell function
[42,48]. Therefore, these results strongly suggest that the
activation of TLR3 signaling prior to virus infection may
induce premature stimulation of regulatory immune
mechanisms, hindering anti-viral immune cell function
and leading to viral persistence. On the other hand,
further activation of TLR3 signaling after viral infection
appears to enhance anti-viral T cell function by redu-
cing the expression of inhibitory PDL-1 and preventing
the generation of regulatory T cells. These observations
are particularly important, as the results imply that
TLR-mediated stimulation of innate immunity as an
intervention strategy for the treatment of viral infections
could exacerbate the development of chronic immune-
mediated disease. Therefore, the timing of innate immu-
nity stimulation should be carefully considered.
Conclusions
We reported previously that TLR3-mediated signaling is
important in the induction of innate cytokine responses
to TMEV infection. In this study, we investigated the
role of TLR3-mediated signaling in the development of
TMEV-induced demyelinating disease. TLR3KO mice in
the susceptible SJL background displayed increased cel-
lular infiltration and viral loads in the CNS, accompa-
nied by exacerbated development of demyelinating
disease. Activation of TLR3 with poly IC prior to viral
infection also exacerbated disease development, whereas
such activation after viral infection slowed disease devel-
opment. An increased viral load in the absence of TLR3
signaling led to elevated cytokine production, cellular
infiltration, and exacerbated development of demyelinat-
ing disease. Activation of TLR3 signaling prior to viral
infection hindered the induction of protective IFN-g-
producing CD4+ and CD8+ T cell populations, but ele-
vated PDL-1 expression and regulatory CD4+ T cell gen-
eration in the CNS. These results suggest that TLR3-
mediated signaling during viral infection protects against
demyelinating disease by reducing the viral load. In con-
trast, premature activation of TLR3 signal transduction
prior to viral infection may induce premature stimula-
tion of regulatory immune mechanisms, hindering anti-
viral immune cell function and promoting viral
persistence.
Additional material
Additional file 1: Genotyping of the presence of TLR3. The presence/
absence of TLR3 in TLR3KO-SJL and the littermate mice (NLM) were
typed based on the electrophoresis patterns of TLR3 and neomycin
resistant genes. PCR products from tail genomic DNA of NLM and TLR
£KO-SJL mice were determined using PCR-based genotyping analysis,
established by the Jackson Laboratory. TLR3 primers (5’-ACT CCT TTG
GGG GAC TTT TG-3 and 5’-CAG GTT CGT GCA GAA GAC AA-3’) and Neo
generic primers (5’-CTT GGG TGG AGA GGC TAT TC-3’ and 5’-AGG TGA
GAT GAC AGG AGA TC-3’) were used for PCR.
Additional file 2: Levels of type I IFNs in poly IC-treated mice. Type I
interferon (IFN-a and IFN-b) levels in the CNS of TMEV-infected SJL mice
treated with poly IC at -1 day (-1D) or +8 days (+8D) or untreated (N)
were determined at 14 dpi using quantitative PCR. Data were expressed
by fold induction after normalization to the GAPDH mRNA levels. The
values given are means ± standard deviation of triplicate. Statistical
significances of the differences were indicated with asterisks (*, P < 0.05;
**, P < 0.01; ***, P < 0.001).
Abbreviations
TLR3: toll-like receptor-3; MS: multiple sclerosis; CNS: central nervous system;
dpi: days post-infection; PFU: plaque forming units; RT-PCR: reverse
transcriptase-polymerase chain reaction; TMEV: Theiler’s murine
encephalomyelitis virus.
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